Literature DB >> 8523079

Degradation of collagen type IV by C6 astrocytoma cells.

R F Del Maestro1, I S Vaithilingam, W McDonald.   

Abstract

The key event associated with the initiation of angiogenesis is the localized degradation of the vascular basement membrane. Because of its complex structure, any remodelling and/or modification of the basement membrane must involve the co-ordinated function of a number of different enzyme systems. Type IV collagen is a major protein component (60-90%) of the basement membrane and its degradation is crucial to the initiation of angiogenesis. This study has focused on the mechanisms by which C6 astrocytoma cells degrade human type IV collagen. C6 astrocytoma cells use components of two major degradative pathways to degrade collagen type IV. The major matrix metalloproteinase identified is the activated form (68-KDa) of gelatinase A (72-KDa matrix metalloproteinase) and a serine sensitive 1000-KDa collagenase type IV degrading activity which appears to have the characteristics of a novel extracellular proteasome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8523079     DOI: 10.1007/bf01052662

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

Review 1.  Tumor interactions with the vasculature: angiogenesis and tumor metastasis.

Authors:  C H Blood; B R Zetter
Journal:  Biochim Biophys Acta       Date:  1990-06-01

Review 2.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture.

Authors:  J Folkman
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

Review 3.  Mechanisms of tumor-associated edema: a review.

Authors:  R F Del Maestro; J F Megyesi; C L Farrell
Journal:  Can J Neurol Sci       Date:  1990-05       Impact factor: 2.104

Review 4.  Proteasomes (multicatalytic proteinase complexes) in eukaryotic cells.

Authors:  K Tanaka; A Ichihara
Journal:  Cell Struct Funct       Date:  1990-06       Impact factor: 2.212

Review 5.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

6.  Structure and function of basement membrane.

Authors:  J R Stanley; D T Woodley; S I Katz; G R Martin
Journal:  J Invest Dermatol       Date:  1982-07       Impact factor: 8.551

7.  Abnormally high expression of proteasomes in human leukemic cells.

Authors:  A Kumatori; K Tanaka; N Inamura; S Sone; T Ogura; T Matsumoto; T Tachikawa; S Shin; A Ichihara
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 8.  Tumoral invasion in the central nervous system.

Authors:  Y A De Clerck; H Shimada; I Gonzalez-Gomez; C Raffel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect.

Authors:  P A Stewart; K Hayakawa; C L Farrell; R F Del Maestro
Journal:  J Neurosurg       Date:  1987-11       Impact factor: 5.115

10.  A matrix metalloproteinase expressed on the surface of invasive tumour cells.

Authors:  H Sato; T Takino; Y Okada; J Cao; A Shinagawa; E Yamamoto; M Seiki
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

View more
  4 in total

1.  Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B.

Authors:  K Watanabe; D Yoshida; M Noha; A Teramoto
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

2.  The expression and activation of matrix metalloproteinase-2 in rat brain after implantation of C6 rat glioma cells.

Authors:  T Kodera; T Nakagawa; T Kubota; M Kabuto; K Sato; H Kobayashi
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

3.  The importance of cell density in the interpretation of growth factor effects on collagenase IV activity release and extracellular matrix production from C6 astrocytoma cells.

Authors:  M Tamaki; W McDonald; R F Del Maestro
Journal:  J Neurooncol       Date:  1998-09       Impact factor: 4.130

4.  Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.

Authors:  Karamkolly R Rekha; Ramu Inmozhi Sivakamasundari
Journal:  Neurochem Res       Date:  2018-08-23       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.